Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Parasite-specific GABA-gated chloride channels are ligand-gated ion channels found predominantly in nematodes (parasitic worms) that mediate inhibitory neurotransmission by allowing chloride ion inflow in response to GABA (gamma-aminobutyric acid) binding, resulting in hyperpolarization and muscle relaxation[1]. These channels are essential for the control of parasite muscle tone and movement and represent a validated therapeutic target for anthelmintics. The classic anthelmintic drug piperazine acts as an agonist at these channels, causing flaccid paralysis in nematodes and facilitating their expulsion[1]. Macrocyclic lactones may also interact with these channels, but their exact mode of action is more established at glutamate-gated chloride channels[1][2]. There is some pharmacological evidence for cyclooctadepsipeptides (e.g., PF1022A, emodepside) interacting with nematode GABA receptors, though not as classical agonists[1]. These channels are members of the Cys-loop ligand-gated ion channel superfamily and are structurally distinct from mammalian GABA-A receptors, providing parasite selectivity and thus a therapeutic window. Schistosomes (flatworms) do not possess clear genes encoding GABA-gated chloride channels, restricting this target to nematodes[1]. Safety concerns primarily relate to potential cross-reactivity with host receptors, though drugs are designed for parasite selectivity, and to the emergence of drug resistance.
Agonism (e.g., piperazine acts as an agonist, causing channel opening and subsequent muscle relaxation/flaccid paralysis in parasites); Allosteric modulation (possible for macrocyclic lactones; precise action may vary between compounds)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parasite-specific GABA-gated chloride channel.